Company
Medpace Holdings, Inc.
Headquarters: Cincinnati, OH, United States
Founded: 1992
Employees: 4,500
CEO: Dr. August James Troendle M.D.
Market Cap
$9.37 Billion
USD as of July 1, 2025
Medpace Holdings, Inc. Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $162.07 B |
| Danaher | $144.92 B |
| Siemens Healthineers AG | $64.17 B |
| Lonza Group Ltd | $49.67 B |
| IDEXX Laboratories, Inc. | $43.99 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | $2.16 B |
| EBITDA | $485.5 M |
| Gross Profit TTM | $1.47 B |
| Profit Margin | 19.31% |
| Operating Margin | 20.32% |
| Quarterly Revenue Growth | 9.30% |
Stocks & Indices
Medpace Holdings, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MEDP wb_incandescent
Stock: BMV: MEDP wb_incandescent
Stock: FSX: 01P wb_incandescent
Product & Services
Support services for pharmaceutical and medical device
Key People
Dr. August J. Troendle, President and CEO